Eastwood Bio-Medical Canada Receivables

The latest receivables for EBM.V is $37K as of July 2024. That compares with $25K in the prior-year period — up 51.0% year over year. Investors often review this figure alongside Eastwood Bio-Medical Canada's historical trend and sector peers before judging valuation or financial health.

Over the past year, EBM.V's receivables moved from $25K to $37K — a 51.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Eastwood Bio-Medical Canada's operating scale or balance-sheet position.

A receivables figure of $37K for EBM.V is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting EBM.V's receivables ($37K), review year-over-year change from $25K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.